Weekly CDC News Overview – November 30-December 6, 2025

This is a brief overview of major news about CDC from the past week. In this overview, I describe the major themes from news coverage about CDC, reference important insights and events, and include hyperlinks to all relevant news articles.

Confusion Over Vaccine Guidance and Emerging Evidence on COVID-19 Risks in Pregnancy

Several articles this week highlighted challenges in public understanding of CDC vaccine guidance and renewed scrutiny of COVID-19 risks during pregnancy. These stories underscore the continued problems with CDC failing to communicate evidence clearly during an evolving respiratory season.

• ProPublica reported on public confusion surrounding CDC guidance about maternal vaccination. The outlet summarized new research suggesting elevated risks associated with COVID-19 infection during pregnancy. One expert noted that “clear communication remains essential for pregnant people to make informed decisions.”
• ABC News examined claims about pediatric vaccine safety. Physicians quoted in the article emphasized the need for transparent evidence review. One pediatrician stated that “assertions about causality require rigorous data.”

Federal Leadership Changes and Public Controversy Around Vaccine Policy

New leadership appointments at HHS and CDC advisory committees received widespread coverage. Some reporting described controversial statements from new federal appointees, raising concerns about the direction of vaccine policy and the integrity of advisory processes.

• Reuters reported on the appointment of a new chair of the CDC vaccine advisory committee.
• Endpoints News highlighted prior remarks made by the incoming ACIP chair. The story emphasized how misleading claims about vaccine harms can weaken trust in federal immunization programs.
• Associated Press reported that the previous ACIP chair was reassigned to a new HHS role.

Related: Vaccine Safety: A Comprehensive Guide

• HHS formally announced the appointment of Martin Kulldorff to a senior position.

Staffing Reductions and Operational Deficits at CDC

Multiple outlets documented ongoing workforce challenges at CDC. These reports consistently described the consequences of sustained staff reductions and organizational uncertainty.

• NPR reported that months of staff cuts have weakened morale and capacity. The story quoted one staff member saying that “every department feels stretched thin.”
• The New Yorker described long-term structural risks to the agency’s ability to respond to public health threats. The analysis warned that “capacity has eroded at the very moment it is most needed.”
• WCVB reported that mass layoffs have disrupted CDC’s longstanding pregnancy surveillance systems.

National Debate Over Hepatitis B Vaccination for Newborns

State agencies, medical organizations, and editorial writers emphasized the scientific basis for routine hepatitis B vaccination at birth. These pieces addressed misinformation about the vaccine and underscored the risks of delaying immunization.

• Connecticut Department of Public Health reaffirmed its recommendation for administering the hepatitis B vaccine to newborns.
• Hepatitis B Foundation reported findings that delays in the birth dose could lead to thousands of preventable infections. One analysis noted that postponement “creates lifelong risks that are entirely avoidable.”
• The New York Times argued that altering birth-dose policy would harm public health and increase disparities.

AI Modernization and Early Results at CDC

Coverage of federal modernization efforts highlighted early benefits from CDC’s investment in artificial intelligence. These stories documented improved analytic speed and predictive modeling capacity.

• NextGov reported that CDC’s early adoption of AI tools has streamlined complex analyses and supported faster decision-making.

HIV Policy and World AIDS Day Reflections

Several outlets covered the administration’s failure to support HIV prevention and to recognize World AIDS Day. Reporting highlighted the implications of federal funding decisions and the perspectives of public health leaders.

• PBS NewsHour examined the effect of federal actions on HIV prevention programs.
• WABE interviewed experts who reflected on HIV epidemiology and the future of prevention.

Misinformation and Politicization of Public Health

Several articles documented how political actors continue to question vaccine safety, antidepressant use, and other established science. These stories illustrate ongoing threats to public trust in evidence-based policy.

• MedPage Today reported on claims by RFK Jr. regarding scientific standards. The outlet noted that such statements often “misrepresent how evidence is generated and evaluated.”
• MedPage Today also documented new vaccine-related attacks lacking scientific foundation.
• The Week described new efforts to link antidepressants to mass violence, despite limited evidence for such claims.
• Southworth PC cited polling showing declining public confidence in federal agencies.

Health Priorities and Policy Direction Under the Administration

Coverage of internal federal discussions provided insight into the administration’s emerging health agenda. These stories described shifts in program priorities, including their potential implications for CDC’s future capacity.

• NPR reported that a closed-door federal summit addressed upcoming changes in health policy.